Drug Science

Can BDA’s medical cannabis product treat long-COVID symptoms?

Finfeed Archived Mar 18, 2021

Bod Australia Limited (ASX: BDA) has entered into a collaboration agreement with the UK’s leading independent scientific body on drugs, Drug Science UK, which has the potential to unlock a large market opportunity for BDA in the treatment of long-term symptoms of COVID-19.